Conditions: Ehlers-Danlos Syndrome Hypermobility Type (hEDS); Ehlers-Danlos Syndrome (EDS); Joint Hypermobility; Joint Instability; Hypermobility Spectrum Disorder; Chronic Pain Syndrome; Musculoskeletal Pain; Sprain; Subluxation; Dislocation; Craniocervical Disfunction
Interventions: Drug: Dextrose 20% Prolotherapy; Biological: Autologous Platelet-Rich Plasma; Drug: Doxycycline Hyclate Injectable (Investigational); Device: Visco-3 Sodium Hyaluronate Viscosupplementation
Sponsors: Manhattan Pain Medicine, PLLC
Not yet recruiting Conditions: Ehlers-Danlos Syndrome Hypermobility Type (hEDS); Ehlers-Danlos Syndrome (EDS); Joint Hypermobility; Joint Instability; Hypermobility Spectrum Disorder; Chronic Pain Syndrome; Musculoskeletal Pain; Sprain; Subluxation; Dislocation; Craniocervical Disfunction
Interventions: Drug: Dextrose 20% Prolotherapy; Biological: Autologous Platelet-Rich Plasma; Drug: Doxycycline Hyclate Injectable (Investigational); Device: Visco-3 Sodium Hyaluronate Viscosupplementation
Sponsors: Manhattan Pain Medicine, PLLC
Not yet recruiting
